Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 6

The predictive value of preoperative neutrophillymphocyte and platelet-lymphocyte ratio on overall survival in patients with operable gastric cancer

Pages
1689–1694
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aim: Elevated preoperative neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) predict overall survival ratesamong patients with several types of cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Elevated preoperative neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) predict overall survival ratesamong patients with several types of cancer.
📊
Key Findings & Data:The current study was conducted to clarify whether NLR and PLR are clinically usefulin predicting overall survival among patients undergoing curative resections for gastric cancer.Material and Methods: 202 gastric cancer patients were reviewed retrospectively who had been appealed to our clinic between 2006and 2013. 192 patients who had local disease, and underwent curative surgery for gastric cancer were included to the study.
💡
Conclusion & Impact:In multivariate analysis, metastasis at follow up (p=0.014; HR:1.81;CI:1,126-2,911) and LNR (p=0.001; HR:3,564; CI:2,175-5,842) were found to be independent variables with worse overall survival.Conclusion: Preoperative NLR and PLR cannot be used as independent variables for prediction of overall survival in patients withoperable gastric cancer.
🔬Design:Review & Systematic Survey
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Elevated preoperative neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) predict overall survival ratesamong patients with several types of cancer. The current study was conducted to clarify whether NLR and PLR are clinically usefulin predicting overall survival among patients undergoing curative resections for gastric cancer.Material and Methods: 202 gastric cancer patients were reviewed retrospectively who had been appealed to our clinic between 2006and 2013. 192 patients who had local disease, and underwent curative surgery for gastric cancer were included to the study. Dataregarding potential prognostic factors including age, sex, preoperative neutrophil, lymphocyte, and platelet counts, postoperativetumor characteristic such as tumor location, tumor size, lymph node metastasis, tumor–nodes–metastasis staging, Lauren'sclassification of subtypes and survival times were obtained from medical records.Results: No significant correlations were noted between NLR, PLR and tumor location, size, Lauren's classification of subtypes,histology, stage, and type of gastrectomy. Univariate analysis revealed that metastasis at the follow up, sex, T, N stage, and lymphnode ratio (LNR) were predictors of worse overall survival. In multivariate analysis, metastasis at follow up (p=0.014; HR:1.81;CI:1,126-2,911) and LNR (p=0.001; HR:3,564; CI:2,175-5,842) were found to be independent variables with worse overall survival.Conclusion: Preoperative NLR and PLR cannot be used as independent variables for prediction of overall survival in patients withoperable gastric cancer.

🔖

Cite This Article

YILDIZ, B. D., ÖZDEN, S., ER, S., TEZ, M., GÜNDOĞDU, S. B., BİRBEN, B. (2022). The predictive value of preoperative neutrophillymphocyte and platelet-lymphocyte ratio on overall survival in patients with operable gastric cancer. Annals of Medical Research, Cilt: 27 - Sayı: 6, 1689–1694. https://ajindex.com/articles/446390

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019;14:26-38
  2. Graziosi L, Marino E, De Angelis V, et al. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer. Am J Surg 2015;209:333-7
  3. Kim EY, Lee JW, Yoo HM, et al. The Platelet-toLymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer? Ann Surg Oncol 2015;22:4363-70
  4. Jiang N, Deng J-Y, Liu Y, et al. The role of preoperative neutrophil–lymphocyte and platelet–lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers 2014;19:444-51
  5. Aliustaoglu M, Bilici A, Ustaalioglu BBO, et al. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol. 2010;27:1060-5
  6. Gunaldi M, Goksu S, Erdem D, et al. Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J Clin Exp Med 2015;8:5937-42
  7. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99
  8. Wang D-s, Ren C, Qiu M-z, et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol 2012;33:749-56
  9. Forrest LM, McMillan DC, McArdle CS, et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 2003;89:1028-30
  10. Kim JH, Lee JY, Kim HK, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio and plateletto-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol 2017;23:505- 15
  11. Yodying H, Matsuda A, Miyashita M, et al. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2016;23:646-54
  12. Caliskan S, Sungur M, Kaba S, et al. Neutrophil-tolymphocyte ratio in renal cell carcinoma patients. Folia Med (Plovdiv) 2018;60:553-7
  13. Chen G, Zhu L, Yang Y, et al. Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis. Technol Cancer Res Treat 2018;17:1533033818791500
  14. Wang F, Liu ZY, Xia YY, et al. Changes in neutrophil/ lymphocyte and platelet/lymphocyte ratios after